美女免费一级视频在线观看

    • <form id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></form>
      <address id=BiMYPaeIF><nobr id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></nobr></address>

      Ashley Allan is making history in her role as executive director for CAH brand marketing at Neurocrine Biosciences, overseeing a cross-functional team that launched the first treatment for CAH (a group of rare genetic conditions impacting the adrenal glands) in over 50 years. 
      




      Before entering the rare disease space, Allan spent five years at Edwards Lifesciences where she spearheaded an award-winning direct-to-consumer campaign that raised diagnosis and treatment rates. Prior to that, she spent three years at Takeda, where she restructured and centralized Shire’s nursing services model, aligning patient care with brand strategies. And at Neurocrine Biosciences, she recently championed the What the CAH?! campaign, a playful yet impactful initiative that resonated deeply with the CAH community.
      




      Outside the office, Allan is a rock drummer, a certified sommelier, an avid cyclist and the proud owner of two dogs who are often by her side. 
      




      Click here to return to the 2025 MM+M 40 Under 40 homepage.
      


                        
                        
                        
                        

      
	
		From the January 01, 2025 Issue of MM+M - Medical Marketing and Media